Recent News

Device hits pancreatic tumors hard with toxic four-drug cocktail, sparing the body

Device hits pancreatic tumors hard with toxic four-drug cocktail, sparing the body

A new implantable device delivers first-line treatment for pancreatic cancer directly to tumors, bypassing bloodstream and limiting widespread side effects. A team of researchers from the University of North Carolina including Drs. Jen Jen Yeh and Joseph DeSimone, has shown in preclinical research that the device can deliver a particularly toxic dose of drugs directly to pancreatic tumors to stunt their growth or, in some cases, shrink them. This approach would also spare the patient toxic side effects.

Device hits pancreatic tumors hard with toxic four-drug cocktail, sparing the body - Read More…

Zika, emerging viruses focus of UNC virology seminar

Zika, emerging viruses focus of UNC virology seminar

Zika, the virus currently causing worldwide concern due to its alarming connection to a neurological birth disorder, was discussed as part of a presentation on emerging infectious diseases for the UNC Lineberger-led seminar series titled "Virology in Progress." Helen Lazear, PhD, a UNC Lineberger member and an assistant professor in the UNC School of Medicine Department of Microbiology and Immunology, spoke about Zika and noted that experts know relatively little about the virus.

Zika, emerging viruses focus of UNC virology seminar - Read More…

Physicians issue advice, raise questions about best practices for evaluating blood in the urine as a sign of cancer

Physicians issue advice, raise questions about best practices for evaluating blood in the urine as a sign of cancer

A new report from the American College of Physicians’ High Value Care Task Force issues advice for physicians on how to detect and evaluate blood found in the urine, which is known as hematuria. The report, which was first-authored by UNC Lineberger Comprehensive Cancer Center member Dr. Matthew Nielsen, also raises questions about the potential harms associated with diagnostic tests that are commonly employed to evaluate this condition.

Physicians issue advice, raise questions about best practices for evaluating blood in the urine as a sign of cancer - Read More…

UNC Lineberger joins nation’s cancer centers in endorsement of HPV vaccination for cancer prevention

UNC Lineberger joins nation’s cancer centers in endorsement of HPV vaccination for cancer prevention

UNC Lineberger Comprehensive Cancer Center has joined 68 of the nation's top cancer centers in urging increased vaccination for the human papillomavirus, or HPV. Recognizing insufficient vaccination rates present a public health threat, this nationwide network of experts is calling upon physicians, parents and young adults to take advantage of this rare opportunity to prevent many types of cancer.

UNC Lineberger joins nation’s cancer centers in endorsement of HPV vaccination for cancer prevention - Read More…